Shea Molly E, Hiasa Hiroshi
Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA.
J Biol Chem. 2003 Nov 28;278(48):48485-90. doi: 10.1074/jbc.M304217200. Epub 2003 Sep 17.
Quinolone antimicrobial drugs target both DNA gyrase and topoisomerase IV (Topo IV) and convert these essential enzymes into cellular poisons. Topoisomerase poisoning results in the inhibition of DNA replication and the generation of double-strand breaks. Double-strand breaks are repaired by homologous recombination. Here, we have investigated the interaction between the RuvAB branch migration complex and the Topo IV.quinolone.DNA ternary complex. A strand-displacement assay is employed to assess the helicase activity of the RuvAB complex in vitro. RuvAB-catalyzed strand displacement requires both RuvA and RuvB proteins, and it is stimulated by a 3'-non-hybridized tail. Interestingly, Topo IV.quinolone.DNA ternary complexes do not inhibit the translocation of the RuvAB complex. In fact, Topo IV.quinolone.DNA ternary complexes are reversed and displaced from the DNA upon their collisions with the RuvAB complex. These results suggest that the RuvAB branch migration complex can actively remove quinolone-induced covalent topoisomerase.DNA complexes from DNA and complete the homologous recombination process in vivo.
喹诺酮类抗菌药物作用于DNA旋转酶和拓扑异构酶IV(Topo IV),并将这些必需酶转化为细胞毒素。拓扑异构酶中毒会导致DNA复制受到抑制以及双链断裂的产生。双链断裂通过同源重组进行修复。在此,我们研究了RuvAB分支迁移复合物与Topo IV-喹诺酮-DNA三元复合物之间的相互作用。采用链置换分析来评估RuvAB复合物在体外的解旋酶活性。RuvAB催化的链置换需要RuvA和RuvB蛋白两者,并且受到3'-非杂交尾的刺激。有趣的是,Topo IV-喹诺酮-DNA三元复合物并不抑制RuvAB复合物的移位。事实上,Topo IV-喹诺酮-DNA三元复合物在与RuvAB复合物碰撞时会从DNA上被逆转并置换下来。这些结果表明,RuvAB分支迁移复合物可以主动从DNA上去除喹诺酮诱导的共价拓扑异构酶-DNA复合物,并在体内完成同源重组过程。